IL2 and COVID-19: NKG2A was shown to be upregulated in severe COVID-19 patients by Zheng et al., alongside decreased functional activity indicated from the decrease of intracellular cytokines CD107a, interferon-γ (IFN-γ), IL-2, and TNF-α [72].